
ã³ãããŠã€ã«ã¹ã®ææé²æ¢å¯Ÿçã«åãçµãã§ããŸãã
ææé²æ¢å¯Ÿçã®è©³çްã¯ãã¡ã
ã³ãããŠã€ã«ã¹ã®ææé²æ¢å¯Ÿçã«åãçµãã§ããŸãã
ææé²æ¢å¯Ÿçã®è©³çްã¯ãã¡ã
åŠåš 9é±ç®ä»¥åã®NIPTæ€æ»ãåéããããŸãã
10é±ç®ä»¥éã®æ€æ»ãã»ããã§
åããŠããã ããŸãã®ã§
æ€æ»ã2ååããããŸãã
æ©æã®æ€æ»çµæ
ïŒåºŠã®æ€æ»ã§å®å¿çŽåŸã®æ€æ»çµæ
ä»ã§ã¯ã§ããªãæ€æ»

ãçžè«ã»ãäºçŽã¯ãã¡ããŸã§
åãä»ããŠãããŸãã
æ°ååºçå蚺æã»NIPT Topics

ã¡ãã£ã¢åºæŒæ å ±
å¹³ç³ã¯ãªããã¯ã®é¢é·ã§ããå¹³ç³è²Žä¹ ã2021幎2æ3æ¥æŸéã®ããžãã¬ãããã³ãã§ã£ã!?TVãã»ããã³ãã§ã£ã!?人ççžè«ãããããããªããã¯ã¢ãã¿æ¬¡ç¬¬ããã«åºçå蚺æè©è«å®¶ãšããŠåºæŒããŸãããã»ãããŒæ å ±
ããããåºçå蚺æãç¹ã«NIPTãåããããšæ€èšãããŠããæ¹åãã«åºçå蚺æã®ããšãæ£ããçè§£ããŠããã ããããå®å¿ããçŽåŸããŠæ€æ»ã«åãåããããã«éå¬ãããŠããã ããŸãããã»ãããŒã®åç»ã¯ãã¡ã


èª¿æ»æŠèŠïŒ2019幎,2020幎,2021幎1-7æ,æ°ååºçå蚺æãµãŒãã¹ã«å¯Ÿãã顧客æºè¶³åºŠèª¿æ»ã
ãçžè«ã»ãäºçŽã¯ãã¡ããŸã§
åãä»ããŠãããŸãã
![]() |
æ¥æ¬ããŒã±ãã£ã³ã°ãªãµãŒãæ©æ§ã調æ»ãè¡ã£ããæ°ååºçå蚺æãµãŒãã¹ã«å¯Ÿãã顧客æºè¶³åºŠèª¿æ»ãã«ãããŠã2019幎床ã®é¡§å®¢æºè¶³åºŠ95ïŒ
ã2020幎97%ã2021幎1-7æ95%ãç²åŸããããšãã§ããŸããã |
---|---|
![]() |
äžè¬çã«35æ³ä»¥äžã«ããåºçå蚺æã¯æ¡å
ãããŸãããåœé¢ã®NIPTã¯å¹Žéœ¢å¶éã¯ãªãã倫婊å䌎ã§ãªããšåããããªããªã©ã®å¶éãããããŸããã®ã§ãå®å¿ããŠå蚺ããããšãã§ããŸãã |
![]() |
åœé¢ã§ã¯æ€æ»çµæãéœæ§ã®å Žåãæ¥æ¬åœå
ã®ã©ã¡ãã§æ€æ»ãåããŠããã ããŠããçŸæ°Žæ€æ»è²»çšã¯å
šé¡è² æ
ããããŸãã |
![]() |
1åã®ãæ¥é¢ã®ã¿ã§æ¡è¡ãå¯èœã§ãæ€æ»çµæãæ¡è¡ããæç6æ¥ã§ãäŒãããããšãã§ããŸãã |
![]() |
åœé¢ã§ã¯æ€æ»ã®ç³èŸŒæžãšåææžã«ãèšå ¥ããã ããŸããŠãå蚺ã®ããšæ¡è¡ãšãªããŸãã倫婊å䌎ããåããŸãé£ãã§ã®å蚺ããã¡ããå¯èœã§ãã |
ãçžè«ã»ãäºçŽã¯ãã¡ããŸã§
åãä»ããŠãããŸãã
NIPTïŒæ°ååºçå蚺æïŒãšã¯ïŒ
æ¯äœããæ¡è¡ããŠè¡æ¶²ãæ€æ»ã
èå
ã®æè²äœç°åžžã調ã¹ãæ€æ»ã®ããšã§ãã
æ°ååºçå蚺æïŒNIPTïŒãšã¯ããæ¯ããŸã®è¡æ¶²ããèå ã®ããŠã³çãªã©ã®æè²äœç°åžžã調ã¹ãããšãã§ããæ€æ»ã§ããåœé¢ã¯ãåŠå©Šæ§ã»ãå®¶ææ§ã«æ£ããæè²äœç°åžžã®ç¥èããæäŸãããçè§£ããã ããäžã§åºçåã®æ€æ»ãåããŠããã ããŸãã

éåžžäºæ¬ã®å¯Ÿããªãæè²äœã䞡芪ãããããã1æ¬ãã€åãç¶ãåè£ã®éã«ãããçªå·ã®æè²äœã«ãããŠ3æ¬ã«ãªã£ãŠããŸã£ãç¶æ ã®ããšãããªãœããŒãšãããŸãã
åºæ¬æ€æ»ã®ããªãœããŒæ€æ»ãšã¯ãåžžæè²äœã®13çªïŒãããŒçå矀ïŒã18çªïŒãšãã¯ãŒãºçå矀ïŒã21çªïŒããŠã³çåçŸ€ïŒæè²äœãããªãœããŒã®çŸæ£ãããã®ããæ€æ»ããŸãã
æ§æè²äœã¯ãå ã ç·å¥³ã§æ¬æ°ãç°ãªããæ£åžžå¥³æ§ã§ã1æ¬ä»¥å€ã¯äžæŽ»æ§åãšèšã£ãп޻åãæãããããããªãœããŒãããã©ãœããŒïŒéåžž2æ¬ã®æè²äœã4æ¬ã®ç¶æ ïŒã«ãªã£ãŠãéå°ãªæè²äœã¯äžæŽ»æ§åããŠç©è³ªã®çç£ã®å€åã¯å°ãããåžžæè²äœããªãœããŒãšæ¯èŒããŠçç¶ã¯è»œããäžççºèŠãããªãå ŽåããããŸãããçšã«é床ã®é害ããæ§å¥ã«åœ±é¿ãäžããæè²äœã§ããããäžåŠãçæ®åšã®å¥åœ¢ãèµ·ããããšããããŸãã
æ§æè²äœæ€æ»ã§æ€åºã§ããæè²äœç°åžž
[åç§°]
ã¿ãŒããŒçå矀ïŒXOïŒ
[çºç確ç]
2,000-3,000人ã«1人
[äž»ãªçç¶]
äœèº«é·ãç¹åŸŽç身äœå
åãåµå·£æ©èœäžå
šã«ããäºæ¬¡æ§åŸŽãæçµç°åžžãªã©ãæãããããæ§è
ºæ©èœäžå
šãäž»ç
æ
ãšãããããäžåŠãšãªãå Žåãå€ãã
[åç§°]
ã¯ã©ã€ã³ãã§ã«ã¿ãŒçå矀ïŒXXYïŒ
[çºç確ç]
1,000人ã«1人
[äž»ãªçç¶]
åŠç¿é害ãé·ãè
ãšèãå°ããªç²Ÿå·£ãç¡ç²Ÿåçã«ããäžåŠç
[åç§°]
XXXçå矀ïŒXXXïŒ
[çºç確ç]
1,000人ã«1人
[äž»ãªçç¶]
軜ãç¥çé害ãã¿ãããã ãã§ãã»ãã«çç¶ã¯ãããŸãããå€é°éšãåµå·£ãåå®®ãè
ã«ç°åžžã¯ãªããäºæ¬¡æ§åŸŽãã»ãšãã©ããµã€ãã«çŸããŸããåŠåš ã»åºç£ãå¯èœã§ããã®åã©ãã®å€§éšåã¯æ£åžžãªæè²äœããã£ãŠçãŸããŸããæ¯èŠªã®é«éœ¢åºç£ã§çãŸããé »åºŠãé«ããšããããŸãã
[åç§°]
XYYçå矀ïŒXYYïŒ
[çºç確ç]
1,000人ã«1人
[äž»ãªçç¶]
äžçãéããŠæ°ã¥ãããªãå Žåãå€ããæè¿ã¯åæ§ã®ç¯çãšããèŠæ¹ãäžè¬çãé«èº«é·ãå€åãç¥èœã®äœäžãªã©ãçŸãããšããå ±åããããéã«ç¥èœãé«ããšããå ±åãããã
åºæ¬æ€æ»ã§ãã13çªã18çªã21çªãå«ã1çªãã22çªãŸã§ã®æè²äœã®ããªãœããŒæ€æ»ã«ãªããŸãã
åžžæè²äœã¯åœéçµ±äžåœåæ³ã§ãé·ã(ãšèãããã)é ã«1ãã22ãŸã§çªå·ãæ¯ãããããä»ã§ã¯ãå®ã¯é·ãã®èšç®ãéã£ãŠããããšã倿ããããçªå·ã¯å€ããã«åŒã°ããŠããŸãïŒïŒïŒçªãšïŒïŒçªæè²äœã®é·ãã¯éã«ãªã£ãŠããŸãïŒã
13çªã18çªã21çªä»¥å€ã®æè²äœã«ç°åžžããã£ãå Žåã¯ãéºäŒåæ°ã®å€ãæè²äœçŸæ£ã«åœããçºãåºçåã«æ·æ±°ããåºçã«è³ããªãã±ãŒã¹ã極ããŠé«ãã§ããããããªãããã¢ã¶ã€ã¯åïŒæ£åžžãªæè²äœãšç°åžžã®ããæè²äœãæ··åšããç¶æ ïŒã§ããå Žåã¯ããçšã«åºçã«è³ãäºããããŸããåºççã¯äœããªãããïŒïŒ ã§ã¯ãããŸããã
ããªãœããŒæ€æ»ã§ã¯æ€ç¥ã§ããªããæè²äœã®åŸ®çŽ°ãªæ¬ å€±ãæ€æ»ããŸãã
æè²äœã®é·ãæ¹ãé·è (q)ãçãæ¹ãçè (p)ãšãããäŸãã°1ïœ36æ¬ æçãšã¯ã1çªæè²äœã®çè ã36é åãæ¬ æããŠããçŸæ£ã«ãªããŸããåŸ®å°æ¬ å€±æ€æ»ã§æ€åºã§ããã®ã¯äžèšã®æè²äœç°åžžã«ãªããŸãã
[åç§°]
1p36æ¬ å€±çå矀
[çºç確ç]
25,000-40,000人ã«1人
[äž»ãªçç¶]
æé·é害, é床粟ç¥çºéé
æ», 飿²»æ§ãŠããããªã©
[åç§°]
4pæ¬ å€±çå矀 ïŒWolf-Hirschhorn SyndromeïŒãŠã©ã«ãã»ãã«ã·ã¥ããŒã³çå矀ïŒ
[çºç確ç]
50,000人ã«1人
[äž»ãªçç¶]
æé·é害ãé床粟ç¥é
æ»ãçç·åŒµäœäžã飿²»æ§ãŠããããæé£é害ãªã©
[åç§°]
5pæ¬ å€±çå矀 ïŒCri-Du-Chat SyndromeïŒç«é³Žãçå矀ïŒ
[çºç確ç]
15,000-50,000人ã«1人
[äž»ãªçç¶]
äœåºçäœéãæé·é害ãç²é«ãç«ã®ãªã声ã®ãããªåŒæ³£ãçç·åŒµäœäžã粟ç¥éåçºéã®é
ããªã©
[åç§°]
ãã©ããŒã»ãŠã£ãªçå矀⻠ïŒPrader-Willi syndromeïŒ
[çºç確ç]
15,000人ã«1人
[äž»ãªçç¶]
å
åæ³åŠçç°åžžïŒè¥æºãäœèº«é·ãæ§è
ºæ©èœé害ãç³å°¿ç
ãªã©ïŒãç¥çµåŠçç°åžžïŒçç·åŒµäœäžãç¹åŸŽçãªæ§æ Œé害ãç°åžžè¡åïŒãçç·åŒµäœäžã«ããåºä¹³é害ãäºæ¬¡æ§åŸŽçºæ¥äžå
šãæ§æ Œé害ãªã©
[åç§°]
ã¢ã³ãžã§ã«ãã³çå矀â»ïŒAngelman SyndromeïŒ
[çºç確ç]
15,000人ã«1人
[äž»ãªçç¶]
é床ã®ç²Ÿç¥çºéã®é
ãããŠãããã倱調æ§éåé害ãè¡åç°åžžãç¡ç é害ãäœè²çŽ çãªã©
[åç§°]
22q11.2æ¬ å€±çå矀 ïŒDiGeorge SyndromeïŒãã£ãžã§ãŒãžçå矀ïŒ
[çºç確ç]
4,000-5,000人ã«1人
[äž»ãªçç¶]
çºéé
å»¶ãå
倩æ§å¿è¡ç®¡çŸæ£ãå£èè£ãèžè
ºäœåœ¢æãäœã«ã«ã·ãŠã è¡çãªã©
â»15q11-q13æ¬ å€±çåçŸ€ïŒæè²äœ15q11-13é åã«ååšããéºäŒå矀ã¯ããã®ç±æ¥ãç¶èŠªãæ¯èŠªãã«ããåããããšãªã£ãŠãããããåãéºäŒåç°åžžã§ãã£ãŠããç¶èŠªç±æ¥ã® éºäŒåçŸ€ã®æ¬ 倱ã§ã¯Prader-WilliçåçŸ€ãæ¯èŠªç±æ¥ã®æ¬ 倱ã§ã¯Angelmançå矀ãšããå šãç°ãªãçŸæ£ãšãªããïŒ
äžèšã®æè²äœç°åžžã調ã¹ãããšãã§ããŸãã
åŠå©Šããããã®ããããªæ¡è¡ã§æ€æ»ãã§ãããããæ¯äœãžã®è² æ
ãå°ãªããæµç£ãææçã®ãªã¹ã¯ããªãã®ãæå€§ã®ç¹åŸŽã§ãã
ãã®ä»ã«ããæ€æ»ç²ŸåºŠãé«ããããåŠåš æ©æã§ãæ€æ»ã§ããããšãã£ãã¡ãªããããããŸãã
æè²äœãšã¯
ããã®çްèã«ã¯46æ¬ã®æè²äœããããããããã2æ¬1çµã®å¯ŸãæããŠããŸãããã®ãã¡22察ïŒ44æ¬ïŒã¯åžžæè²äœãšåŒã°ãç·å¥³ã«å ±éããŸãããæ®ãã®1å¯Ÿã¯æ§å¥ã決ããæ§æè²äœãšãããç·æ§ã¯ïŒžïŒ¹ã女æ§ã§ã¯ïŒžïŒžãæã¡ãŸããç¶èŠªãšæ¯èŠªããããããåãéºäŒåæ å ±ãå«ã1æ¬ãã€ãåãç¶ãããã®æè²äœ2æ¬ã1察ãšããŠæ©èœããŠããŸãã
NIPTïŒæ°ååºçå蚺æïŒæ€æ»ã£ãŠïŒ
åŠåš äžãã»ã«ããªãŒDNAãèç€ããæŒåºãããæ¯ããã®è¡æ¶²ã®äžã埪ç°ããŠããŸãããã®ãããæ¯äœè¡äžã«ã¯èå
ç±æ¥ã®ã»ã«ããªãŒDNAãšæ¯äœç±æ¥ã®ã»ã«ããªãŒDNAãæ··åšããŠããŸããNIPTæ€æ»ã§ã¯ãã®èå
ç±æ¥ã»ã«ããªãŒDNAã®éºäŒåé
åãè§£èªããããšã§ãDNAæçãäœçªæè²äœã«ç±æ¥ããŠããããå€å®ããæè²äœç°åžžãæ€åºããŸãã
æ°ååºçå蚺æãšãããéåžžã«ç²ŸåºŠã®é«ãæ€æ»ãå¯èœã«ãªããŸããã
NIPTïŒæ°ååºçå蚺æïŒæ€æ»ã®æµã

ãé»è©±ãããã¯æ¬ãµã€ãã®æ€æ»äºçŽãã©ãŒã ãããç³èŸŒã¿ãã ããã

ãäºçŽããã ããæ¥æã«ãæå®ã®æ¡è¡å»çæ©é¢ã«ãæ¥é¢ãã ããã

æ¡è¡åŸæ€æ»æ©é¢ã«è¡æ¶²ãçºéããæ€æ»ãè¡ããŸãã

æ€æ»æ¥ããæç6æ¥ã§æ€æ»çµæãéç¥ãããŠããã ããŸãã
ãçžè«ã»ãäºçŽã¯ãã¡ããŸã§
åãä»ããŠãããŸãã
NIPTïŒæ°ååºçå蚺æïŒæ€æ»æŠèŠ
â»æ€æ»åã«å¿
ããèªã¿ãã ãã
æ€æ»å¯Ÿè±¡ãšãªãæ¹
åŠåš 10é±ä»¥éã®åèåŠåš ãåèåŠåš ã®æ¹*ïŒæ³š1ïŒãæ€æ»å¯èœã§ãã幎霢å¶éã¯ãããŸãããããã·ã³ã°ãã€ã³*ïŒæ³š2ïŒã®æ¹ã¯ç³èŸŒæã«å¿ ããç³åãã ããã
ãåžæã®æ¹ã«ã¯æ§å¥ããç¥ããããããŸã
ãåžæã®æ¹ã¯æ§å¥ããç¥ããã§ããŸããæ€æ»çµæã®çšçŽã«æ§å¥ãèšèŒããŠãéãããããŸãã
â»æ¡è¡ä»¥éã«æ§å¥éç¥ã®å€æŽã¯ãåãã§ããŸããã
ïŒïŒæ³š1ïŒåèåŠåš ã®æ¹ã¯æ€æ»ã«å¶éããããŸãã®ã§ã確èªãã ããã
æ€æ»çµæãéœæ§ã®å Žåããã²ãšããéœæ§ããŸãã¯ãäºäººãšãéœæ§ãšããæ€æ»çµæã«ãªããŸãã
æ§æè²äœæ€æ»ã¯ã§ããŸããã
æ§å¥å€å®ã¯ãyæè²äœãæ€ç¥ããå Žåãã²ãšããç·å
ããããã¯ãäºäººãšãç·å
ãšããçµæã«ãªããŸãã
ïŒïŒæ³š2ïŒããã·ã³ã°ãã€ã³ïŒåèäžå æ»äº¡ïŒã®å Žå
NIPT忀æ¥ã«ãããããŸãã®ã§äœé±ã®æã«å»åž«ãã蚺æãåããããå¿ ããç³åãã ããã
æ€æ»è²»çš
(1ïœ22çªããªãœããŒæ€æ»)
ïŒ1ïœ22çªããªãœããŒæ€æ»ïŒ
ïŒ1p36æ¬ å€±çå矀ã4pæ¬ å€±çå矀ã5pæ¬ å€±çå矀ããã©ããŒã»ãŠã£ãªçå矀ãã¢ã³ãžã§ã«ãã³çå矀ã22q11.2æ¬ å€±çå矀ïŒ
ãAåºæ¬æ€æ»ãBå
šæè²äœæ€æ»ã«é¢ããŠã¯ãã€ã«ããç€Ÿã®æ¬¡äžä»£ã·ãŒã±ã³ãµãŒNextSeq550Dxã䜿çšãåœå
æ€æ»ã宿œããŠãããŸãã
ãã®åœå
æ€æ»ã§äœ¿çšããŠããNextSeq550Dxã¯ãNIPTæ€æ»ã«å¯Ÿå¿ããã€ã«ããç€Ÿã®æ¬¡äžä»£ã·ãŒã±ã³ãµãŒã§å¯äžãã¯ã©ã¹â
å»çæ©åšç»é²ãããæ©åšã«ãªããŸãã
åœé¢ã§ã¯ãAåºæ¬æ€æ»ãBå
šæè²äœæ€æ»ã«é¢ããŠã¯ããã®NextSeq550Dxãå«ããVeriSeqNIPT Solution V2ãšããæ€æ»ææ³ã§ã®å®æœã«ãªããŸãã

ã€ã«ããç€Ÿã®æ¬¡äžä»£ã·ãŒã±ã³ãµãŒNextSeq550Dxãšããã«ãã³ã»ã«ã³ãããŒã»ãžã£ãã³ã®èªååæ³šåšMicrolab STARã䜿çšããNIPT枬å®ã«ãããåæ³šã®æäœæ¥ãèªååæ³šåšã«ãããªãŒãã¡ãŒã·ã§ã³åããäžé£ã®å·¥çšã誀差ããã¥ãŒãã³ãšã©ãŒã鲿¢ããæ€æ»ææ³ãæ¹è¯ãããè§£æã¢ã«ãŽãªãºã ãç·æ¬ããŠVeriSeq NIPT Solution V2ãšãããŸãã
ãVeriSeq NIPT Solution V2ãã¯åŸæ¥ã®æ€æ»æ³ããåªããŠããç¹ã¯ãæ€æ»ç²ŸåºŠïŒéœæ§çäžçïŒã«ãªããŸãã
éœæ§çäžç |                    Âé°æ§çäžç | |
Trisomy 13 | 92.8% | 99.99%ä»¥äž |
Trisomy 18 | 95.3% | 99.99%ä»¥äž |
Trisomy 21 | 98.4% | 99.99%ä»¥äž |
ãéœæ§çäžçãšã¯ãéœæ§ãšå€å®ãããæ¹ãå®éã«éœæ§ã®å Žåã®çäžçã«ãªããŸãããã®éœæ§çäžçãé«ãã»ã©ãåœéœæ§ïŒéœæ§ãšå€å®ãããæ¹ãå®éã¯é°æ§ã®å ŽåïŒãå°ãªããªããæ¬æ¥å¿ èŠã®ãªãçŸæ°Žæ€æ»ãçµšæ¯æ€æ»ãªã©ã®äŸµè¥²çãªæ€æ»ãæããããšãã§ããŸãã
             Ââ»VeriSeq NIPT Solution V2ã䜿çšããŠã®æ€æ»ã¯ãæè²äœç°æ°æ§ã®æ€æ»ãããŠã¯ãé«ãæ€æ»ç²ŸåºŠãèªããŸããããããåŸ®å°æ¬ 倱çå矀ã®å€ãã¯ãVeriSeq NIPT Solution V2ã®è§£æã¢ã«ãŽãªãºã ã§ã¯æ€åºã§ããªãåŸ®çŽ°ãªæ¬ 倱ãšãªããããæµ·å€ã§ã®æ€æ»ãšãªããŸãã
éœæ§ã ã£ãå Žåããã®åŸã®çŸæ°Žæ€æ»è²»çšã¯å šé¡åœé¢ãè² æ ããããŸãã
â»çµšæ¯æ€æ»ãåŸ®å°æ¬ 倱ã®çŸæ°Žæ€æ»ãå šé¡è² æ ããããŸãã
æ€æ»çµæã¯ã¡ãŒã«ã«ãŠãç¥ããããããŸãã
â»æ¡è¡å»çæ©é¢ã®æ±ºæžæ¹æ³ã«æºããŸãã
â»èªç±èšºçã®ããä¿éºé©çšå€ãšãªããŸãã
å岿ãïŒéå©ææ°æïŒåïŒããå©çšããã ããŸãã
ãåžæã®æ¹ã¯åä»ã»ã³ã¿ãŒãžãé£çµ¡äžããã
â»ã¯ãªããã¯çŸå°ã§ã¯ã察å¿ã§ããŸããã
ãçžè«ã»ãäºçŽã¯ãã¡ããŸã§
åãä»ããŠãããŸãã
ããããã質å
NIPTïŒæ°ååºçå蚺æïŒã«ã€ããŠ
åœé¢ã®NIPTïŒæ°ååºçå蚺æïŒã¯ã幎霢å¶éããªãã倫婊å䌎ã§ãªããšåããããªããªã©ã®å¶éã埡座ããŸããã®ã§ãå®å¿ããŠå蚺ããããšãã§ããŸãã
çŸæ°Žæ€æ»ãçµšæ¯æ€æ»ãšéããæµç£ã®ãªã¹ã¯ããªããæ¡è¡ã®ã¿ã§ãããªãã粟床ã®é«ãæ€æ»ã§ãã
åºçå蚺æã«ã¯ãç¢ºå®æ€æ»ãšéç¢ºå®æ€æ»ïŒã¹ã¯ãªãŒãã³ã°æ€æ»ïŒããããŸãã ç¢ºå®æ€æ»ã«ã¯ãçŸæ°Žæ€æ»ãšçµšæ¯æ€æ»ããããŸãã ç¢ºå®æ€æ»ã¯ç²ŸåºŠãé«ããšããã¡ãªããããããŸãããæµç£ã®ãªã¹ã¯ããããŸãã éç¢ºå®æ€æ»ã«ã¯ãNIPTæ€æ»ãã¯ã¯ãããã¹ãçã®æ¯äœè¡æž ããŒã«ãŒããããŸãã æ¯äœè¡æž ããŒã«ãŒã¯æµç£ã®ãªã¹ã¯ã¯ãããŸããããæ€æ»ç²ŸåºŠãé«ããããŸããã NIPTã¯ãã¯ã¯ãããã¹ãçã®åŸæ¥ã®åºçå蚺æãšåãããæµç£ã®ãªã¹ã¯ããªãããªããã€é«ãæ€æ»ç²ŸåºŠãèªãæ€æ»ã«ãªãçºãåŸæ¥ã®åºçå蚺æãšåºå¥ããçºãæ°ååºçå蚺æïŒNIPTïŒãšãã°ããŠããŸãã
åœé¢ã®NIPTæ€æ»ã§ã¯ã13ããªãœããŒïŒãããŒçå矀ïŒã18ããªãœããŒïŒãšãã¯ãŒãºçå矀ïŒã21ããªãœããŒïŒããŠã³çå矀ïŒãæ§æè²äœç°åžžãå šæè²äœç°åžžãåŸ®å°æ¬ å€±ã®æ€æ»ãå¯èœã§ãã
åèã®æ¹ãŸã§æ€æ»å¯èœã§ãã ãã ããæ€æ»çµæãéœæ§ã®å Žåããã²ãšããéœæ§ããŸãã¯ãäºäººãšãéœæ§ãšããæ€æ»çµæã«ãªããŸãã
NIPTã®äºçŽã«é¢ãã質å
åŠåš ãåãã£ãæç¹ã§ãäºçŽé ããŸãã
æ¡è¡æ©é¢ã倿°ãããNIPTïŒæ°ååºçå蚺æïŒæ€æ»ã®ãäºçŽã¯åªå çã«åä»ããŠãããŸãã®ã§ãæ¯èŒçãäºçŽã¯åãããããªã£ãŠãããŸãã åœæ¥ã®ãäºçŽãåä»ããŠãããŸããããæå®ã®æ¥æãããå Žåã¯ãæ©ãã®ãäºçŽãããããããŠãããŸãã
NIPTïŒæ°ååºçå蚺æ)æ€æ»ã«ã€ããŠ
ãæ¥é¢é ããŠãããæŠã30åçšåºŠã¿ãŠé ããã°ãšæããŸãã
åææžã«åŠåš 鱿°ãèšèŒé ããŸãã®ã§ããæ¬äººæ§ã®ç¢ºèªçšã«æ¯åæåž³ããæã¡ããã ããããæ¡å ããŠãããŸãããåŠåš 鱿°ãææ¡ããŠé ããŠããã°ãæ¯åæåž³ãç¡ããŠãåé¡ãªãæ€æ»ãåããããŸãã
æ€æ»å¯èœã§ãã
NIPTã®çµæã«é¢ãã質å
æç6æ¥ïœ14æ¥ã»ã©ã§ã¡ãŒã«ã«ãŠãç¥ããããããŸããæ€æ»äŒç€Ÿã®æ··éç¶æ³ãDNAã®æ¡åã«é¢ããŠæéããããæ¹ãããã£ããããŸãããããŸã§ãç®å®ãšããŠ10æ¥ã»ã©ã«ãªããŸãã®ã§ããäºæ¿äžããããŸããæ€æ»é ç®ãçµæã®å 容ã«ãã£ãŠæ€æ»ã«ãããæ¥æ°ãå€åããããšã¯ããããŸããã
æ€æ»çµæããã¡æ©ããç¥ããããçºãã¡ãŒã«ã«ãŠãç¥ãããããŠé ããŸããååæ€è æ§ããããã«ã»ãã¥ãªãã£ãŒã®çºããã¹ã¯ãŒãããããç¶æ ã§ãã¡ãŒã«ã«ãŠæ·»ä»ãããŠé ããŸãã
æ€æ»åŸã«æ§å¥ã®éç¥ã远å ããããšã¯ã§ããããŸãã
æ§å¥ã®éç¥ã¯æ€æ»åœæ¥ã«èšèŒé ãåææžã«ãŠéžæããŠé ããŸãã®ã§ãæ€æ»åœæ¥ãŸã§ã«ãçžè«ã®äžããæ¥é¢äžããã
æ€æ»çµæãšãäžç·ã«æ€æ»çµæã®èª¬ææžãæ·»ä»èŽããŸããããäžæç¹ãããããŸãããã説æãããŠé ããŸãã
ãŸãã«ã§ãããèå
ã®DNAã®æ¡åãé£ãããæ€æ»ãã§ããªãå ŽåãããããŸãã
ãŸããåå ã¯ç¹å®ã§ããªãã®ã§ãããæ€æ»ãããæ¹ã®äœèª¿ã«ããããèµ€è¡çãç Žå£ãããããæº¶è¡ããšããçŸè±¡ã§æ€æ»ãã§ããªãå ŽåãããããŸãã
ãã®éã¯åæ€æ»ãšãªããŸãããè²»çšã¯ããããŸããã
æ€æ»ãéœæ§ã ã£ãå ŽåãçŸæ°Žæ€æ»ã®è²»çšã¯åœé¢ãå
šé¡è² æ
ããããŸããå»çæ©é¢ã®æå®ã¯ããããŸãããæ
åœå»ãšãçžè«ã®äžããåžæã®å»çæ©é¢ã«ãŠæ€æ»ããåãäžããã
â»æ€æ»æ©é¢ãžã®äº€éè²»çã¯ã客æ§è² æ
ãšãªããŸãã
NIPTïŒæ°ååºçå蚺æ)ã®æéã«é¢ãã質å
忀æ»è²»çšã¯äžåããããŸããã
å¯èœã§ããäœèª¿ã®å€åãèããææã ãšæããŸãã®ã§ãäœèª¿äžè¯ãªã©ãããããŸããããé£çµ¡äžããã
倿Žã«äŒŽãè²»çšã¯ããããŸããã
ãäºçŽæ¥åœæ¥ã§ãã£ãŠããæ¡è¡åã§ããã°ãã£ã³ã»ã«æã¯ããããŸããã
ã¯ã¬ãžããã«ãŒããŸãã¯çŸéã§ã®ãæ¯æãã«ãªããŸããçŸéãšã¯ã¬ãžããã«ãŒãã®äœµçšãã察å¿èŽããŸãã
ïŒâ»æ¡è¡å»çæ©é¢ã®æ±ºæžæ¹æ³ã«æºããŸããïŒ
ãã®ä»NIPTã«é¢ãã質å
NIPTïŒæ°ååºçå蚺æ)ã¯å»çä¿éºã®é©çšå€ãšãªããŸãã
NIPTïŒæ°ååºçå蚺æ)ã¯å»çè²»æ§é€ã®å¯Ÿè±¡å€ãšãªããŸãã
ãçžè«ã»ãäºçŽã¯ãã¡ããŸã§
åãä»ããŠãããŸãã
é¢é·ç޹ä»
å¹³ç³ è²Žä¹ ïŒãã©ã€ã· ã¿ã«ããµïŒ
1950幎鹿å
å³¶ççãŸãã
æ±äº¬æ
æµäŒå»ç§å€§åŠåæ¥ã
å°éã¯å
ç§ãæ¶ååšç§ãã¹ããŒãå»åŠã
ãã€ã§ãé Œãã«ãªãå»çããããã«æ¥ã
é²åããå»çãåžžã«èº«è¿ã«ãçæ§ã«ãšã£ãŠããªãã§ãçžè«åºæ¥ããããªã¯ãªããã¯ãç®æããŠãããŸãã
æ°žå¹ŽãæŸå°ç·æ²»çãå
ç«æ²»çãç ç©¶ããããæ²»çã«é¢ãã£ãŠããŸããããåãçåœã§ããæ°çå
ã«é¢ããå¥åº·ã«ãçç®ããæµç£ã®ãªã¹ã¯ãæå€§éã«æããNIPTïŒæ°ååºçå蚺æïŒã«ã察å¿ããäºã決æèŽããŸããã
é«éœ¢åºç£ãå¢ããŠããåŸåã«ããæ¥æ¬ã§ãæµç£ã®ãªã¹ã¯ãæããæ€æ»ãåºæ¥ãNIPTïŒæ°ååºçå蚺æïŒã®éèŠæ§ãé«ãèããåºãæ€æ»ãç¥ãæž¡ãã¿ãªããŸã«å©çšããŠããã ããäºãç®æããŠãããŸãã
å»åž«å
èš±ååŸå¹Ž:1977幎12æ
åœé¢å€åéå§å¹ŽïŒ2017幎11æ
å¹³ç³ã¯ãªããã¯ã®ã¢ã¯ã»ã¹
NIPTå¹³ç³ã¯ãªããã¯
ã106-0045
ãæ±äº¬éœæž¯åºéº»åžåçª1-9-7
ã麻åžKFãã«7F
ã麻åžåçªé§
5çªåºå£ãåŸæ©1å
â 蚺çæé
ãåå10:00 â ååŸ17:00
â äŒèšºæ¥
ãäžå®äŒ
å šåœã®ææºã¯ãªããã¯äžèЧ
æ€æ»äºçŽã»ãåãåãã
æ€æ»æ¥æã»å
容確èªã®ããã
ãå
¥åããã ããŸããé»è©±çªå·ã«
æãè¿ããé£çµ¡ãããŠããã ããŸãã
æè¿ãããããŠããã ãéã®
ãåžæã®æé垯ãªã©ã埡座ããŸãããã
åèæ¬ã«ãå
¥åããã ããã°ãšåããŸãã